|
Au, Jessie L-S; Jang, Seong H; Wientjes, M Guill (2002) Clinical aspects of drug delivery to tumors. J Control Release 78:81-95
|
|
Jang, S H; Wientjes, M G; Au, J L (2001) Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J Pharmacol Exp Ther 298:1236-42
|
|
Jang, S H; Wientjes, M G; Au, J L (2001) Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Invest New Drugs 19:113-23
|
|
Au, J L; Jang, S H; Zheng, J et al. (2001) Determinants of drug delivery and transport to solid tumors. J Control Release 74:31-46
|
|
Li, D; Au, J L (2001) Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein. Pharm Res 18:907-13
|
|
Jang, S H; Wientjes, M G; Au, J L (2001) Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J Pharmacol Exp Ther 296:1035-42
|
|
Millenbaugh, N J; Wientjes, M G; Au, J L (2000) A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect. Cancer Chemother Pharmacol 45:265-72
|
|
Kuh, H J; Jang, S H; Wientjes, M G et al. (2000) Computational model of intracellular pharmacokinetics of paclitaxel. J Pharmacol Exp Ther 293:761-70
|
|
Song, S; Wientjes, M G; Gan, Y et al. (2000) Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc Natl Acad Sci U S A 97:8658-63
|
|
Kuh, H J; Jang, S H; Wientjes, M G et al. (1999) Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther 290:871-80
|
Showing the most recent 10 out of 27 publications
